Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. - Wikidata - awgldk - TriplyDB

Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.

Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.

http://www.wikidata.org/entity/Q34432555

about

Endometrial cancer: what is new in adjuvant and molecularly targeted therapy?Improving oncologic outcomes for women with endometrial cancer: realigning our sights Development of targeted therapy in uterine serous carcinoma, a biologically aggressive variant of endometrial cancer An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers.erbB2 Overexpression in Uterine Serous Cancer: A Molecular Target for Trastuzumab Therapy.Management of women with surgically staged 1 uterine papillary serous cancer.High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinoma Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment.Clear cell cancer of the uterine corpus: the association of clinicopathologic parameters and treatment on disease progression Endometrial serous carcinoma (uterine papillary serous carcinoma): precancerous lesions and the theoretical promise of a preventive approach.Trends in the demographic and clinicopathological characteristics in Japanese patients with endometrial cancer, 1990-2010.Brain metastasis in two patients with stage IA papillary serous carcinoma of the uterus.The impact of combined radiation and chemotherapy on outcome in uterine papillary serous carcinoma compared to chemotherapy alone.An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.New candidate therapeutic agents for endometrial cancer: potential for clinical practice (review).A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium.Uterine papillary serous carcinoma: a review.A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system.Personalized care in uterine cancer.Endometrial serous carcinoma: its molecular characteristics and histology-specific treatment strategies.Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer.Molecular target therapies in endometrial cancer: from the basic research to the clinic.Pharmacotherapy of endometrial cancer.Taxanes: their impact on gynecologic malignancy.Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer.Clinicopathologic study in uterine cancer.No cookie-cutter oncology: individualized treatment approaches for women with corpus endometrial cancer.Unresolved issues in the management of endometrial cancer.Clinical management of uterine papillary serous carcinoma.Alteration in PI3K/mTOR, MAPK pathways and Her2 expression/amplification is more frequent in uterine serous carcinoma than ovarian serous carcinoma.Surgical Treatment of Recurrent Endometrial Cancer: Time for a Paradigm Shift.Evaluation of adjuvant therapy in women with uterine papillary serous cancer.Should all patients with serous and clear cell endometrial carcinoma receive adjuvant chemotherapy?Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic characteristics.Abdominal wall metastasis of uterine papillary serous carcinoma in a post-menopausal woman: a case report.Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma.Prognostic impact of lymphadenectomy in uterine serous cancer.[Pitfalls in the histopathological diagnostics of endometrial carcinoma and its precursors : Clinically relevant differential diagnoses, avoidance of false positive diagnoses].Clinical Behavior and Treatment of Endometrial Cancer.

P2860

Q33633962-7344D68A-CE13-4B96-8C23-3747D17B4456 Q33926124-5CDED03E-78EA-49F7-B625-E1227071D159 Q34634149-F11E3FEF-3ABB-4117-9B9D-AA915A42C4BC Q34996963-3D0362DB-100E-4135-9159-D389E082B698 Q35174196-243369FE-ADAA-4D71-B819-E6D8F2FC2C15 Q35207926-76D0E0EF-FFFA-40E1-B92B-A88249A6D8F6 Q35210293-93BA6023-D4E7-4A80-B55F-853D49B25741 Q35517957-1AC2DC14-D8ED-47B1-AB14-865B9FDA5813 Q35609272-F1A14F1C-8C6E-4F95-9442-6120A7406BFC Q36003197-C4758496-61FF-4462-9FD0-A6217511DF7B Q36008845-B4C82F36-40FC-4EAD-BA35-36AEEB055A87 Q36039847-44A3B7E0-7D13-41DA-91A0-819EA23B32D4 Q36475131-36DA74D7-28AF-4FFC-91CA-F122CF27D093 Q36600227-EFAB8FB7-7E61-4CCE-88C6-EDA1ADDEAFFD Q36684551-725BE366-977C-4E50-B054-5646D6CF13F1 Q36737086-8F19C02B-BA81-46E4-968F-E1372F028760 Q36787306-D12E03EC-851B-47E9-85F8-B7CEBAA02582 Q36817475-CB2F6D98-BE8F-4D87-B6C7-DACDDD36C7E2 Q37006856-4CF983D6-4059-4F95-B142-685F707E6BEA Q37017041-2147120F-66F6-40AE-BCDF-C41F4B07BA0A Q37148408-B1B2D192-335A-4FD0-BD55-AC8531A113E6 Q37196543-4E84BBFA-8C89-48B5-AC26-510548921222 Q37544822-D1016DE3-46AB-448B-B11A-690D235A8EEC Q37692801-31A5448D-9F36-4108-9951-6D013AF62305 Q37699264-2A5BCCD1-EA4B-47D1-92E1-1E0294757CFD Q37709899-BB50B864-CDB8-4E3A-B35F-9D806605A27D Q37774355-A991D4F7-DF35-48CF-9CF1-58E479CAE6AE Q37821897-8F568BF4-FE85-42D7-B8F1-E808881D5FC2 Q37821898-B468E155-7FB2-4C22-8A01-9E414D5A0AFA Q38297206-1C19D4BC-9F54-4D89-AB3F-27FDCE3172B7 Q38380255-CA2E8423-C814-4C22-B087-3323507FA989 Q39677120-892F4757-591B-4808-86A5-F4225EAB40D4 Q39811675-0B8C1301-6E29-4561-9529-9BB93394D3E9 Q41721420-CD89B67F-1946-4A12-9198-85196559C51F Q41970635-A7BEE0AA-BCBA-43E5-A310-18448C2164AE Q44953646-6E716AA7-30F3-46FB-A586-7DA6ED56386B Q46078660-FE742C37-DA21-46C2-ACCB-5483B6C6CDA8 Q47347535-33EFA53B-D5F4-4C93-95B5-875023043807 Q52981800-B43D116F-FC8C-4CAD-9A9C-BB700577E099 Q54011680-DC7FC47B-B6A3-452D-9031-96180A7B64B6

P2860

Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.

http://www.wikidata.org/entity/Q34432555

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Improved survival in surgical ...... t platinum-based chemotherapy.

@ast

Improved survival in surgical ...... t platinum-based chemotherapy.

@en

Improved survival in surgical stage I patients with uterine papillary serous carcinoma

@nl

type

label

Improved survival in surgical ...... t platinum-based chemotherapy.

@ast

Improved survival in surgical ...... t platinum-based chemotherapy.

@en

Improved survival in surgical stage I patients with uterine papillary serous carcinoma

@nl

prefLabel

Improved survival in surgical ...... t platinum-based chemotherapy.

@ast

Improved survival in surgical ...... t platinum-based chemotherapy.

@en

Improved survival in surgical stage I patients with uterine papillary serous carcinoma

@nl

P1433

Q34432555-2AA41A9A-38FE-4C25-8F80-CF58984EE59C

P1476

Q34432555-26452107-DC53-4576-AED6-480DB4EAA978

P2093

Q34432555-09CE978D-EF6B-4391-9566-D4F86355A8D8

Q34432555-16A83694-F5AE-4E26-8FB6-4F280A031FCA

Q34432555-2702A840-E114-424B-87B9-92606ABAA501

Q34432555-282FCDEB-8650-4023-B65C-D98276AE6256

Q34432555-4FDEEDD6-63C2-45DE-8E15-C139AC0DDD2B

Q34432555-8C8898AA-1401-43C6-8753-8BF9C72DC591

Q34432555-9363FCB2-E387-478E-822E-9EEF653F0ABA

Q34432555-CE651BE7-D202-487D-A1CA-C59C18577F40

P304

Q34432555-C16DF2E8-FB57-49C5-B0DC-65C0DC6868F9

P31

Q34432555-9FA86B89-C8EE-4031-921F-C38CA393B236

P356

Q34432555-B60AA37C-BB00-48AE-8BA4-E18AD9BF13B2

P407

Q34432555-324E15F3-BB76-4840-B124-7DAAB4E174BB

P433

Q34432555-D31857CB-B4AC-42BE-B4E1-434D64F54EBF

P478

Q34432555-BCCF2FD9-D7D1-4279-817A-94128DBAC0C3

P577

Q34432555-FD8ADB6A-5653-4C16-AFB7-EBFDAC3A07E8

P698

Q34432555-E7E28766-8FB9-4B98-8900-0379E1B5D17F

P921

Q34432555-2BFF538C-E60C-4D37-A3E9-A8EBCF66A0B3

Q34432555-F15450C4-1360-472C-9881-C854854BE94C

P356

J.YGYNO.2005.06.012

P1433

Gynecologic Oncology

P1476

Improved survival in surgical ...... t platinum-based chemotherapy.

@en

P2093

David M O'malley

http://www.w3.org/2001/XMLSchema#string

Herbert Yu

http://www.w3.org/2001/XMLSchema#string

Jessica McAlpine

http://www.w3.org/2001/XMLSchema#string

Masoud Azodi

http://www.w3.org/2001/XMLSchema#string

Michael G Kelly

http://www.w3.org/2001/XMLSchema#string

Pei Hui

http://www.w3.org/2001/XMLSchema#string

Peter E Schwartz

http://www.w3.org/2001/XMLSchema#string

Thomas J Rutherford

http://www.w3.org/2001/XMLSchema#string

P304

353-359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YGYNO.2005.06.012

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16005947

http://www.w3.org/2001/XMLSchema#string

P921